Prospects of Stem Cell Therapy for Diabetic Microvascular Complications
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The expectations for the clinical application of stem cell therapy for diabetic microvascular complications are increasing, as stem cell transplantation improves histopathological abnormalities mainly through angiogenesis/protection, nerve elongation/protection, and anti-inflammatory effects.
Citing Articles
Celik Kavaklilar B, Aybi Ozdemir O, Yildirim T, Dikmetas O, Toprak H, Hekimsoy V J Clin Endocrinol Metab. 2023; 109(8):e1623-e1633.
PMID: 38101939 PMC: 11244200. DOI: 10.1210/clinem/dgad738.
References
1.
Takemura S, Shimizu T, Oka M, Sekiya S, Babazono T
. Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model. J Diabetes Investig. 2019; 11(3):545-553.
PMC: 7232293.
DOI: 10.1111/jdi.13164.
View
2.
Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Saijo Y
. Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy. Sci Rep. 2017; 7(1):8484.
PMC: 5559488.
DOI: 10.1038/s41598-017-08921-y.
View
3.
Omi M, Hata M, Nakamura N, Miyabe M, Kobayashi Y, Kamiya H
. Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy. J Diabetes Investig. 2016; 7(4):485-96.
PMC: 4931198.
DOI: 10.1111/jdi.12452.
View
4.
Omi M, Hata M, Nakamura N, Miyabe M, Ozawa S, Nukada H
. Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation. Stem Cell Res Ther. 2017; 8(1):279.
PMC: 5729514.
DOI: 10.1186/s13287-017-0729-5.
View
5.
Makino E, Nakamura N, Miyabe M, Ito M, Kanada S, Hata M
. Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: Cell-free regenerative medicine for diabetic polyneuropathy. J Diabetes Investig. 2019; 10(5):1199-1208.
PMC: 6717901.
DOI: 10.1111/jdi.13045.
View